Conflict of Interest: None
Botulinum Toxin Type A as Migraine Preventive Treatment in Patients Previously Failing Oral Prophylactic Treatment Due To Compliance Issues
Version of Record online: 28 NOV 2007
© 2007 the Authors. Journal compilation © 2007 American Headache Society
Headache: The Journal of Head and Face Pain
Volume 48, Issue 6, pages 900–913, June 2008
How to Cite
Cady, R. and Schreiber, C. (2008), Botulinum Toxin Type A as Migraine Preventive Treatment in Patients Previously Failing Oral Prophylactic Treatment Due To Compliance Issues. Headache: The Journal of Head and Face Pain, 48: 900–913. doi: 10.1111/j.1526-4610.2007.00953.x
- Issue online: 2 JUN 2008
- Version of Record online: 28 NOV 2007
- Accepted for publication September 3, 2007.
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.